Author

Zhixuan Jing

University of Southern CaliforniaORCID 0009-0007-4237-5889Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Benjamin ZimaniD· 1 shared Chehyun NamiD· 1 shared Daniel ArnaudoviD· 1 shared De‐Chen LiniD· 1 shared Joseph A. VargasiD· 1 shared Megha ShethiD· 1 shared Qian YangiD· 1 shared Talia A. WengeriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Benjamin ZimanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ETS1 Orchestrates a Hybrid EMT Program Driving in vivo Metastasis and Immune Evasion

Benjamin Ziman, Talia A. Wenger, Chehyun Nam, Qian Yang, Daniel Arnaudov, Thomas Tilton, Megha Sheth, Zhixuan Jing, Yuhao Pan, Joseph A. Vargas, Yong Teng, Uttam K. Sinha, Young Min Park, De‐Chen Lin

This study identifies ETS1 as a master regulator of a hybrid EMT program in UASCC that drives metastasis and immune evasion, and shows HSP90 inhibitors can target ETS1-driven tumors.

Cancer Research · May 19, 2026Peer-reviewedCancer Biology